Home > News > pSivida signs licence with Beijing Med-Pharm
October 27th, 2005
pSivida signs licence with Beijing Med-Pharm
Abstract:
Global bio-nanotech company pSivida Limited is pleased to announce that it has signed a Licence with Beijing Med-Pharm Corporation for the clinical development, marketing and distribution of pSivida's lead product, BrachySilTM, in China.
Source:
biotech-intelligence.com
Bookmark:
| Related News Press |
Nanomedicine
Tattoo therapy could ease chronic disease: Rice-made nanoparticles tested at Baylor College of Medicine may help control autoimmune diseases September 23rd, 2016
BBI Solutions launches innovative conjugate blocking technology that enhances signal intensity for lateral flow immunoassays September 20th, 2016
Iran to hold intl. school on application of nanomaterials in medicine September 20th, 2016
Graphene nanoribbons show promise for healing spinal injuries: Rice University scientists develop Texas-PEG to help knit severed, damaged spinal cords September 19th, 2016
Materials/Metamaterials
Chains of nanogold – forged with atomic precision September 23rd, 2016
Coffee-infused foam removes lead from contaminated water September 21st, 2016
Containing our 'electromagnetic pollution': MXene can protect mobile devices from electromagnetic interference September 13th, 2016
New material to revolutionize water proofing September 12th, 2016
Announcements
Chains of nanogold – forged with atomic precision September 23rd, 2016
Tattoo therapy could ease chronic disease: Rice-made nanoparticles tested at Baylor College of Medicine may help control autoimmune diseases September 23rd, 2016
Nanotech Grants Options September 22nd, 2016
Coffee-infused foam removes lead from contaminated water September 21st, 2016
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
University Technology Transfer & Patents
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||
